Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.

Source:http://linkedlifedata.com/resource/pubmed/id/12933855

Download in:

View as

General Info

PMID
12933855